Oxidative stress and cancer; the role of hesperidin, a citrus natural bioflavonoid, as a cancer chemoprotective agent

Nutrition and Cancer

Volumn 68, Issue 1, 2016, Pages 29-39

  Ahmadi, Amirhossein ^a   Shadboorestan, Amir ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CARBON TETRACHLORIDE; CATALASE; CISPLATIN; ENDOTOXIN; GLUTATHIONE PEROXIDASE; HESPERIDIN; MERCURY; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE; ANTINEOPLASTIC AGENT; ANTIOXIDANT;

BLADDER CANCER; BRAIN TUMOR; BREAST CANCER; COLORECTAL CANCER; HUMAN; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MELANOMA; MOUTH CANCER; MULTIPLE MYELOMA; NEOPLASM; NONHUMAN; OVARY CANCER; OXIDATIVE STRESS; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SARCOMA; STOMACH CANCER; UTERINE CERVIX CANCER; ANIMAL; DRUG EFFECTS; METABOLISM; NEOPLASMS;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; HESPERIDIN; HUMANS; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84957937421     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1078822     Document Type: Review

References (81)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al.: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, 359-386, 2015.
2. Agnihotri AK, Bahorun T, and, Aruoma OI.: Cancer: global health perspectives. Arch Med Biomed Res 1, 1-9, 2014.
3. Lockhart AC, Reed CE, Decker PA, Meyers BF, Ferguson MK, et al.: Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOGZ4051)†. Annals of Oncology 25, 1039-1044, 2014.
4. Lawrence TS, Haffty BG, and, Harris JR.: Milestones in the use of combined-modality radiation therapy and chemotherapy. Journal of Clinical Oncology 32, 1173-1179, 2014.
5. Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: An overview. Ageing Research Reviews 12, 379-390, 2013.
6. Noda N, and, Wakasugi H.: Cancer and oxidative stress. Journal of the Japan Medical Association 124, 1571-1574, 2000.
7. Jeong MH, Park YS, Jeong DH, Lee CG, Kim JS, et al.: In vitro evaluation of Cordyceps militaris as a potential radioprotective agent. International Journal of Molecular Medicine 34, 1349-1357, 2014.
8. Wilmsen PK, Spada DS, and, Salvador M.: Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem 53, 4757-4761, 2005.
9. Garg A, Garg S, Zaneveld LJD, and, Singla AK.: Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 15, 655-669, 2001.
10. Kamaraj S, Ramakrishnan G, Anandakumar P, Jagan S, and, Devaki T.: Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice. Investig New Drugs 27, 214-222, 2009.
11. Tanaka T, Tanaka T, Tanaka M, and, Kuno T.: Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin. J Biomed Biotechnol 2012, 1-10, 2012.
12. Kamaraj S, Anandakumar P, Jagan S, Ramakrishnan G, Devaki T. Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in mice. Fundam Clin Pharmacol 25, 91-98, 2011.
13. Klaunig JE, Wang Z, Pu X, and, Zhou S.: Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicology and Applied Pharmacology 254, 86-99, 2011.
14. Nordgren M, and, Fransen M.: Peroxisomal metabolism and oxidative stress. Biochimie 98, 56-62, 2014.
15. Inoue M, Sato EF, Nishikawa M, Park AM, and, Kira Y.: Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr MedChem 10, 2495-2505, 2003.
16. Tulard A, Hoffschir F, Boisferon FH, Luccioni C, and, Bravard A.: Persistent oxidative stress after ionizing radiation is involved in inherited radiosensitivity. Free Radic Biol Med 35, 68-77, 2003.
17. Valko M, Rhodes CJ, Moncol J, Izakovik M, and, Mazure M.: Free radicals, metals andantioxidants in oxidative stress-induced cancer. Chemico Biol Inter 160, 1-40, 2006.
18. Fang J, Seki T, and, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Advanced Drug Delivery Reviews 61, 290-302, 2009.
19. Barrera G.: Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncology 2012, 1-21, 2012.
20. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, et al.: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformationand drug resistance. Biochim Biophys Acta 1773, 1263-1284, 2007.
21. Pani G, Galeotti T, and, Chiarugi P.: Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 29, 351-378, 2010.
22. Reuter S, Gupta SC, Chaturvedi MM, and, Aggarwal BB.: Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biology & Medicine 49, 1603-166, 2010.
23. Nguyen T, Nioi P, and, Pickett CB.: The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. Journal of Biological Chemistry 284, 13291-13295, 2009.
24. Wiemer EA.: Stressed tumor cell, chemosensitized cancer. Nature Medicine 17, 1552-1554, 2011.
25. Choudhari SK, Chaudhary M, Gadbail AR, Sharma A, and, Tekade S.: Oxidative and antioxidative mechanisms in oral cancer and precancer: a review. Oral Oncology 50, 10-18, 2014.
26. Mates JM, Segura JA, Alonso FJ, and, Marquez J.: Oxidative stress in apoptosis and cancer: an update. Arch Toxicol 86, 1649-1665, 2012.
27. Honda T, Coppola S, Ghibelli L, Cho SH, Kagawa S, et al.: GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells. Cancer Gene Therapy 11, 249-255, 2004.
28. Choi EJ.: Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice. Life Sciences 82, 1059-1064, 2008.
29. Tuma DJ.: Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic Biol Med 32, 303-308, 2002.
30. Klaunig JE, and, Kamendulis LM.: The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44, 239-267, 2004.
31. Miliauskas G, Venskutonis PR, and, Beek TAV.: Screening of radical scavenging activity of some medicinal and aromatic plants extracts. Food Chem 85, 231-236, 2004.
32. Zhao B, Li X, He R, Cheng S, and, Xin W.: Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14, 175-185, 1989.
33. Chung Y, Chen S, Hsu C, Chang C, and, Chou S.: Studies on the antioxidative activity of Graptopetalum paraguayense E. Walther. Food Chem 91, 419-423, 2005.
34. Juntachote T, and, Berghofer E.: Antioxidative properties and stability of ethanolic extracts of Holy basil and Galangal. Food Chem 92, 193-202, 2005.
35. Bors W, Heller W, Michel C, and, Saran M.: Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol 186, 343-355, 1990.
36. Terao J, Piskula M, and, Yao Q.: Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation. Arch Biochem Biophys 308, 278-284, 1994.
37. Ioku K, Tsushida T, Takei Y, Nakatani N, and, Terao J.: Antioxidative activity of quercetin and quercetin monoglucosides in solution and phospholipid bilayers. Biochem Biophys Acta 1234, 99-104, 1995.
38. Rice-Evans C, and, Packer L. (eds.): Flavonoids in Health and Disease. New York: Dekker, 1998.
39. Prior RL, and, Cao G.: Antioxidant phytochemicals in fruits and vegetables: diet and health implications. Hortic Sci 35, 588-5922000.
40. Procházková D, Boušová I, and, Wilhelmová N.: Antioxidant and prooxidant properties of flavonoids. Fitoterapia 82, 513-523, 2011.
41. Tiwari AK.: Imbalance in antioxidant defense and human diseases: multiple approach of natural antioxidants therapy. Curr Sci 81, 1179-1187, 2001.
42. Birt DF, Hendrich S, and, Wang W.: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacology & Therapeutics 90, 157-177, 2001.
43. Wearne S.: Estimating dietary intakes of flavonoids. In: Wake Up to Flavonoids, Rice-Evans C (ed.). London, UK: Royal Society of Medicine Press, 2000, pp. 35-43.
44. Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, and, Rémésy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 57, 235-242, 2003.
45. Hussein M, and, Othman SM.: Structure activity relationship of antioxidative property of hesperidin. IJPRD 3 (8), 19-29, 2011.
46. Piskula MK.: Soy isoflavone conjugation differs in fed and food-deprived rats. J Nutr 130, 1766-1771, 2000.
47. Baumann J, Wurn G, and, Bruchlausen FV.: Prostaglandin synthase inhibiting O 2- radical scavenging properties of some flavonoids and related phenoic compounds. N-Ss Arch Pharmacol 308, R27-R39, 1979.
48. Rice-Evans CA, Miller NJ, and, Paganga G.: Structure antioxidant activity relationship of flavonoids and phenolic acids. Free Radi Biol Med 20, 933-956, 1996.
49. Cao G, Sofic E, and, Prior RL.: Antioxidant and prooxidant behaviour of flavonoids: structure-activity relationships. Free Rad Biol Med 22, 749-760, 1997.
50. Heijnen CM, Haenen GM, Acker FAV, Vijgh WJFVD, and, Bast A.: Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol In Vitro 5, 3-6, 2001.
51. Miyagi Y, Om AS, Chee KM, and, Bennink MR.: Inhibition of azoxymethane-induced colon cancer by orange juice. Nutr Cancer 36, 224-229, 2000.
52. Kohno H, Taima M, Sumida T, Azuma Y, Ogawa H, et al.: Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett 174, 141-150, 2001.
53. Bharathi E, and, Jagadeesan G.: Antioxidant potential of hesperidin and ellagic acid on renal toxicity induced by mercuric chloride in rats. Biomedicine & Preventive Nutrition 4, 131-136, 2014.
54. Bharathi E, Jagadeesan G, and, Vijayakumar M.: Hepato-ameliorative effect of hesperidin and ellagic acid on mercuric chloride intoxicated rats. Biomedicine & Aging Pathology 4, 17-21, 2014.
55. Kaur G, Tirkey N, and, Chopra K.: Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology 226, 152-160, 2006.
56. Balakrishnan A, and, Menon VP.: Effect of hesperidin on matrix metalloproteinases and antioxidant status during nicotine-induced toxicity. Toxicology 238, 90-98, 2007.
57. Jagdish K, Mehul S, and, Nehal S.: Effect of hesperidin on serum glucose, HbA1c and oxidative stress in myocardial tissue in experimentally induced myocardial infarction in diabetic rats. Pharmacognosy Journal 2 (7), 185-189, 2010.
58. Yamini K, and, Gopal V.: Natural radioprotective agents against ionizing radiation: an overview. International Journal of PharmTech Research 2, 1421-1426, 2010.
59. Pradeep K, Park SH, and, Ko KC.: Hesperidin a flavanoglycone protects against γ-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats. European Journal of Pharmacology 587, 273-280, 2008.
60. Kalpana KB, Devipriya N, Srinivasan M, Vishwanathan P, Thayalan K, et al.: Evaluating the radioprotective effect of hesperidin in the liver of Swiss albino mice. European Journal of Pharmacology 658, 206-212, 2011.
61. Pradeep K, Ko KC, Choi MH, Kang JA, Chung YJ, et al.: Protective Effect of hesperidin, a citrus flavanoglycone, against γ-radiation-induced tissue damage in Sprague-Dawley rats. J Med Food 15, 419-427, 2012.
62. Said UZ, Saada HN, Abd-Alla MS, Elsayed ME, and, Amin AM.: Hesperidin attenuates brain biochemical changes of irradiated rats. International Journal of Radiation Biology 88, 613-618, 2012.
63. Ahmed HM, Hussein MA, and, Alazonee AS.: Radioprotective effect of hesperidin against gamma-irradiation-induced oxidative stress and biomechanical properties of bone in rats. Life Science Journal 10, 2857-2865, 2013.
64. Shagirtha K, and, Pari L.: Hesperetin, a citrus flavonone, protects potentially cadmium induced oxidative testicular dysfunction in rats. Ecotoxicology and Environmental Safety 74, 2105-2111, 2011.
65. Arafa HMM, Aly HAA, Abd-Ellah MF, and, El-Refaey HM.: Hesperidin attenuates benzo[α] pyrene-induced testicular toxicity in rats via regulation of oxidant/antioxidant balance. Toxicology and Industrial Health 25, 417-427, 2009.
66. Al-Jasabi S, and, Abdullah MS.: The Role of antioxidant hesperidin in the attenuation of lung cancer caused by benzo[a]pyrene in Balb/c mice. World Applied Sciences Journal 22, 1106-1110, 2013.
67. Tirkey N, Pilkhwal S, Kuhad A, and, Chopra K.: Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacology 5, 1-8, 2005.
68. El-Sayed EM, Abo-Salem OM, Abd-Ellah MF, and, Abd-Alla GM.: Hesperidin, an antioxidant flavonoid, prevents acrylonitrile-induced oxidative stress in rat brain. J Egypt Soc Toxicol 37, 87-93, 2007.
69. Tamilselvam K, Braidy N, Manivasagam T, Essa MM, Prasad NR, et al.: Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease. Oxidative Medicine and Cellular Longevity 1-11, 2013.
70. Abdel-Raheem IT, and, Abdel-Ghany AA.: Hesperidin Alleviates doxorubicin-induced cardiotoxicity in rats. Journal of the Egyptian Nat Cancer Inst 21 (2), 175-184, 2009.
71. Sahu BD, Kuncha M, Sindhura GJ, and, Sistla R. Hesperidin attenuates cisplatin-induced acute renal injury by decreasingoxidative stress, inflammation and DNA damage. Phytomedicine 20, 453-460, 2013.
72. Kumar S, Dhankhar N, Kar V, Shrivastava M, and, Shrivastava S.: Myocardial Injury provoked by cyclophosphamide, protective aspect of hesperidin in rats. International Journal of Research in Pharmaceutical and Biomedical Sciences 2, 1288-1296 2011.
73. Javed H, Vaibhav K, Ahmed ME, Khan A, Tabassum R, et al.: Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice. Journal of the Neurological Sciences 348, 51-59, 2015.
74. Pari L, Karthikeyan A, Karthika P, and, Rathinam A.: Protective effects of hesperidin on oxidative stress, dyslipidaemia and histological changes in iron-induced hepatic and renal toxicity in rats. Toxicology Reports 2, 46-55, 2015.
75. Al-Ashaal HA, and, El-Sheltawy ST.: Antioxidant capacity of hesperidin from citrus peel using electron spin resonance and cytotoxic activity against human carcinoma cell lines. Pharm Biol 49, 276-282, 2011.
76. Yang M, Tanaka T, Hirose Y, Deguchi T, Mori H, et al.: Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in MALE ICR mice. Int J Cancer 73, 719-724, 1997.
77. Natarajan N, Thamaraiselvan R, Lingaiah H, Srinivasan P, and, Periyasamy BM.: Effect of flavonone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7. Biomed Prev Nutr 1, 207-215, 2011.
78. Aranganathan S, and, Nalini N.: Efficacy of the potential chemopreventive agent, hesperetin (citrus flavanone), on 1,2-dimethylhydrazine induced colon carcinogenesis. Food Chem Toxicol 47, 2594-2600, 2009.
79. Aranganathan S, Selvam JP, and, Nalini N.: Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Investig New Drugs 27, 203-213, 2009.
80. Nandakumar N, Jayaprakash R, Rengarajan T, Ramesh V, and, Balasubramanian MP.: Hesperidin, a natural citrus flavonoglycoside, normalizes lipid peroxidation and membrane bound marker enzymes in 7, 12-dimethylbenz(a) anthracene induced experimental breast cancer rats. Biomed Prev Nutr 1, 255-262, 2011.
81. Nandakumar N, Haribabu L, Perumal S, and, Balasubramanian MP.: Therapeutic effect of hesperidin with reference to biotransformation, lysosomal and mitochondrial TCA cycle enzymes against 7,12-dimethylbenz(a) anthracene-induced experimental mammary cellular carcinoma. Biomed Aging Pathol 1, 158-168, 2011.